Other

Cytosorbents Corporation

Renaltech International, LLC

Medasorb Corporation

James A Brady

Vadim Davankov

Ludmila Pavlova

James Edward Winchester

Frank M Norris

Peter J Quartararo, Jr

Jamie A Salsberg

Maria Tsyurupa

Maria Tsvurupa

Nathan W Levin

Maria Tsyuruoa

James F Winchester

Vadim Vdavankov

Peter J Quartararo

Devices, systems, and methods reduce levels of pro-inflammatory or anti-inflammatory stimulators or mediators in blood by selective adsorption. The devices, systems, and methods are useful in situations where abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators occur, or during events that do induce or have the potential for inducing abnormal production of pro-inflammatory or anti-inflammatory stimulators or mediators. The devices, systems, and methods serve to prevent, control, reduce, or alleviate the severity of the inflammatory response and disease states that are associated with abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators.

Methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood

Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in blood products

Devices, systems, and methods reduce levels of proinflammatory or anti-inflammatory stimulators or mediators in blood by selective adsorption. The devices, systems, and methods are useful in situations where abnormal levels of or unregulated or excessive interaction among proinflammatory or anti-inflammatory stimulators or mediators occur, or during events that do induce or have the potential for inducing abnormal production of proinflammatory or anti-inflammatory stimulators or mediators. The devices, systems, and methods serve to prevent, control, reduce, or alleviate the severity of the inflammatory response and disease states that are associated with abnormal levels of or unregulated or excessive interaction among proinflammatory or anti-inflammatory stimulators or mediators.

Biocompatible devices, systems, and methods for reducing levels of proinflammatory of antiinflammatory stimulators or mediators in the blood

Biocompatible devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood

Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood, generated as a result of extracorporeal blood processing

Towel dispenser

Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood

A method of peritoneal dialysis includes introducing a dialysis solution into a peritoneal cavity; allowing the dialysis solution to dwell in the peritoneal cavity for a period of time to provide diffusion through an inner lining of an abdominal cavity with exchange of components between a microcirculation of a peritoneum and a dialysis fluid; withdrawing the dialysis solution from the peritoneal cavity with toxins; passing the dialysis solution with toxins through an absorbent polymeric material which has a size, shape, and structure selected so as to remove the toxins in a molecular range of 300-30,000 Dalton from the spent dialysis solution; and returning the thusly purified peritoneal dialysis solution to the patient.

Method of peritoneal dialysis

Growing community of inventors

Southhampton, NY, United States of America

James A Brady